ATE477021T1 - 1,3,5-triazepin-dionen zur behandlung von malaria - Google Patents
1,3,5-triazepin-dionen zur behandlung von malariaInfo
- Publication number
- ATE477021T1 ATE477021T1 AT06847042T AT06847042T ATE477021T1 AT E477021 T1 ATE477021 T1 AT E477021T1 AT 06847042 T AT06847042 T AT 06847042T AT 06847042 T AT06847042 T AT 06847042T AT E477021 T1 ATE477021 T1 AT E477021T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutically acceptable
- treatment
- mammal
- methods
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75563205P | 2005-12-29 | 2005-12-29 | |
PCT/EP2006/070257 WO2007074170A2 (de) | 2005-12-29 | 2006-12-28 | Compositions and methods for the treatment and prevention of disease |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE477021T1 true ATE477021T1 (de) | 2010-08-15 |
Family
ID=37983455
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06847042T ATE477021T1 (de) | 2005-12-29 | 2006-12-28 | 1,3,5-triazepin-dionen zur behandlung von malaria |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1965806B1 (de) |
JP (1) | JP5118648B2 (de) |
CN (1) | CN101400352B (de) |
AT (1) | ATE477021T1 (de) |
AU (1) | AU2006331356B2 (de) |
CA (1) | CA2635356C (de) |
DE (1) | DE602006016168D1 (de) |
WO (1) | WO2007074170A2 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080033167A1 (en) | 2005-12-29 | 2008-02-07 | Gilles Guichard | Compositions and methods for synthesizing heterocyclic therapeutic compounds |
CN114436983B (zh) * | 2021-11-23 | 2023-05-23 | 辽宁中医药大学 | 马齿苋中Oleraze和Oleraoxazine acid及其提取分离方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5663333A (en) * | 1992-10-22 | 1997-09-02 | The Dupont Merck Pharmaceutical Company | Substituted 1,4-diazapine caprolactams useful for treatment of HIV disease |
US6452001B2 (en) * | 2000-05-25 | 2002-09-17 | Hoffmann-La Roche Inc. | Diazapane derivatives useful as antagonists of neurokinin 1 receptor and methods for their formation |
FR2810039B1 (fr) * | 2000-06-13 | 2007-05-25 | Centre Nat Rech Scient | Composes urees cycliques et leur procede de preparation |
US7001899B2 (en) * | 2002-06-10 | 2006-02-21 | The Procter & Gamble Company | Interleukin converting enzyme inhibitors |
-
2006
- 2006-12-28 CN CN200680053560.7A patent/CN101400352B/zh not_active Expired - Fee Related
- 2006-12-28 AU AU2006331356A patent/AU2006331356B2/en not_active Ceased
- 2006-12-28 JP JP2008547974A patent/JP5118648B2/ja not_active Expired - Fee Related
- 2006-12-28 DE DE602006016168T patent/DE602006016168D1/de active Active
- 2006-12-28 CA CA2635356A patent/CA2635356C/en not_active Expired - Fee Related
- 2006-12-28 AT AT06847042T patent/ATE477021T1/de not_active IP Right Cessation
- 2006-12-28 EP EP06847042A patent/EP1965806B1/de not_active Ceased
- 2006-12-28 WO PCT/EP2006/070257 patent/WO2007074170A2/de active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2007074170A3 (de) | 2007-08-23 |
EP1965806B1 (de) | 2010-08-11 |
JP2009522235A (ja) | 2009-06-11 |
WO2007074170A2 (de) | 2007-07-05 |
JP5118648B2 (ja) | 2013-01-16 |
EP1965806A2 (de) | 2008-09-10 |
CN101400352B (zh) | 2016-01-06 |
DE602006016168D1 (de) | 2010-09-23 |
CA2635356C (en) | 2011-11-01 |
CA2635356A1 (en) | 2007-07-05 |
AU2006331356A1 (en) | 2007-07-05 |
AU2006331356B2 (en) | 2011-12-01 |
CN101400352A (zh) | 2009-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1107850T1 (el) | Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους | |
CY1118179T1 (el) | Φαρμακευτικη συνθεση | |
MY148108A (en) | Medicaments for the treatment or prevention of fibrotic diseases | |
DE60336664D1 (de) | Nichtnukleosidische reverse-transkriptase-hemmer | |
WO2005065646A3 (en) | Novel drug compositions and dosage forms | |
RS114004A (en) | Modified 2' and 3'-nucleoside produgs for treating flaviridae infections | |
WO2005063745A8 (en) | Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof | |
NO20050851L (no) | Kaspase-inhibitorer og anvendelser derav | |
WO2006086447A3 (en) | Pyridazine derivatives and their use as therapeutic agents | |
DE60121301D1 (de) | Flibanserin zur Behandlung extrapyramidaler Bewegungsstörungen | |
BRPI0418939A (pt) | derivados de nicotinamida e sua utilização como agentes terapêuticos | |
DOP2005000039A (es) | Hidrocloruro de [4-(5-aminometil-2-fluoro-fenil)- piperidin-1-il]-(4-bomo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos | |
WO2007046867A3 (en) | Piperidine derivatives and their uses as therapeutic agents | |
EA201270144A1 (ru) | Комбинированная терапия при лечении диабета | |
SE0401342D0 (sv) | Therapeutic compounds | |
MX2012000275A (es) | Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal. | |
TW200637544A (en) | Medicaments for the treatment or prevention of fibrotic diseases | |
DE602005010744D1 (de) | Piperazinylpyridinderivate als mittel gegen adipositas | |
RS54050B1 (en) | FORMULATIONS AND METHODS FOR THE TREATMENT OF AMYLOIDOSIS | |
ECSP10010052A (es) | Formulaciones galenicas de alisquireno y valsartan | |
TW200635595A (en) | Medicaments for the treatment of prevention of fibrotic diseases | |
ATE541567T1 (de) | Pharmazeutische zusammensetzung zur prävention und behandlung von metabolischen knochenerkrankungen mit alpha-arylmethoxyacrylat- derivaten | |
WO2006125194A3 (en) | Piperazine derivatives and their uses as therapeutic agents | |
ATE366107T1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
DE60123117D1 (de) | Verwendung von alpha-halogenacryloyl-distamycin derivaten zur herstellung eines medikaments zur behandlung von krebs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |